DGAP-Adhoc: PAION GRANTS EXCLUSIVE LICENSE TO CRISTÁLIA FOR DEVELOPMENT AND COMMERCIALIZATION OF REMIMAZOLAM IN LATIN AMERICA
|
DGAP-Ad-hoc: PAION AG / Key word(s): Contract PAION GRANTS EXCLUSIVE LICENSE TO CRISTÁLIA FOR DEVELOPMENT AND COMMERCIALIZATION OF REMIMAZOLAM IN LATIN AMERICA 27-Apr-2022 / 16:33 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of... |